Reference ranges and cutoff levels of pneumococcal antibody global serum assays (IgG and IgG2) and specific antibodies in healthy children and adults
Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumoc...
Saved in:
Published in | Medical microbiology and immunology Vol. 202; no. 4; pp. 285 - 294 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.08.2013
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0300-8584 1432-1831 1432-1831 |
DOI | 10.1007/s00430-013-0292-3 |
Cover
Loading…
Abstract | Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG
2
antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 μg/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 μg/ml) at age 8–12 years. In parallel, IgG
2
antibodies increased from 20.7 % (0.5–1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson’s coefficient
r
= 0.4455;
p
= 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG
2
assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing. |
---|---|
AbstractList | Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG2 antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 μg/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 μg/ml) at age 8-12 years. In parallel, IgG2 antibodies increased from 20.7 % (0.5-1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson's coefficient r = 0.4455; p = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG2 assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing.Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG2 antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 μg/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 μg/ml) at age 8-12 years. In parallel, IgG2 antibodies increased from 20.7 % (0.5-1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson's coefficient r = 0.4455; p = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG2 assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing. Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG2 antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 μg/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 μg/ml) at age 8-12 years. In parallel, IgG2 antibodies increased from 20.7 % (0.5-1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson's coefficient r = 0.4455; p = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG2 assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing. Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG^sub 2^ antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 [mu]g/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 [mu]g/ml) at age 8-12 years. In parallel, IgG^sub 2^ antibodies increased from 20.7 % (0.5-1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson's coefficient r = 0.4455; p = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG^sub 2^ assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing.[PUBLICATION ABSTRACT] Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG sub(2) antibodies by EIA. In vaccine-naive healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 mu g/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 mu g/ml) at age 8-12 years. In parallel, IgG sub(2) antibodies increased from 20.7 % (0.5-1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson's coefficient r = 0.4455; p = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG sub(2) assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing. Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for immunodeficiencies. Our study generated reference ranges and cutoff levels for pneumococcal antibody global serum assays correlated to a specific pneumococcal antibody ELISA. Specific pneumococcal antibody levels were measured from 457 children undergoing elective surgery and 46 healthy adult volunteers (88 with previous pneumococcal immunization from both groups), 22 severe immunodeficient subjects with ataxia telangiectasia (A-T, negative controls), and age-matched 36 healthy allergic asthmatics. We determined a representative panel of serotype-specific pneumococcal antibodies (serotype 4, 5, 6B, 7F, 14, 18C, 19F, 23F) by ELISA and global pneumococcal IgG and IgG 2 antibodies by EIA. In vaccine-naïve healthy subjects, initial pneumococcal IgG geometric mean concentrations of 13.1 μg/ml were low in the first year of life and increased over the time, reaching adult levels (70.5 μg/ml) at age 8–12 years. In parallel, IgG 2 antibodies increased from 20.7 % (0.5–1 year old) to adult proportions (>30 %) in preschoolers. Correlation between the pneumococcal IgG screening assay and specific pneumococcal antibody levels was acceptable (Pearson’s coefficient r = 0.4455; p = 0.001). Cutoff levels showed high sensitivity, whereas specificity was high to moderate calculated from correlations with the specific ELISA. We provide reference ranges and cutoff levels for the interpretation of specific antibody determinations in the clinical setting. The global pneumococcal IgG/IgG 2 assay is a suitable screening tool and correlates with the ELISA serotype-specific pneumococcal antibodies. However, results below our cutoff values should be re-evaluated by serotype-specific ELISA testing. |
Author | Buess, J. Rose, M. A. Schulze, J. Zielen, S. Ventur, Y. Schubert, R. Herrmann, E. |
Author_xml | – sequence: 1 givenname: M. A. surname: Rose fullname: Rose, M. A. email: Markus.Rose@kgu.de organization: Department of Pulmonology, Children`S Hospital, Allergy, and Cystic Fibrosis, Goethe-University – sequence: 2 givenname: J. surname: Buess fullname: Buess, J. organization: Department of Pulmonology, Children`S Hospital, Allergy, and Cystic Fibrosis, Goethe-University – sequence: 3 givenname: Y. surname: Ventur fullname: Ventur, Y. organization: The Binding Site GmbH – sequence: 4 givenname: S. surname: Zielen fullname: Zielen, S. organization: Department of Pulmonology, Children`S Hospital, Allergy, and Cystic Fibrosis, Goethe-University – sequence: 5 givenname: E. surname: Herrmann fullname: Herrmann, E. organization: Institute of Biostatistics and Mathematical Modelling, Goethe-University – sequence: 6 givenname: J. surname: Schulze fullname: Schulze, J. organization: Department of Pulmonology, Children`S Hospital, Allergy, and Cystic Fibrosis, Goethe-University – sequence: 7 givenname: R. surname: Schubert fullname: Schubert, R. organization: Department of Pulmonology, Children`S Hospital, Allergy, and Cystic Fibrosis, Goethe-University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23529214$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks9q3DAQxkVJaTZpH6CXIuglObgdSbalPZaQfxAIlNyNLI92FWRpK9mFfZC-b7W7SSmBlpxGgt838w3fnJCjEAMS8pHBFwYgv2aAWkAFTFTAl7wSb8iC1YJXTAl2RBYgACrVqPqYnOT8CMBky-EdOeaiKTyrF-TXd7SYMBikSYcVZqrDQM08RWupx5_oM42WbgLOYzTRGO0LMbk-Dlu68rEv_4xpHqnOWW8zPbtdXe97lMrP96-8QeOsM89CV6a4QNeo_bTeUrN2figW9qweZj_l9-St1T7jh6d6Sh6uLh8ubqq7--vbi293lamhmSqheA2KoS3raNMvBRcWjJSWFZ-NbNpWGdloUL3VjelbrWpcDmLQ2Es5oDglZ4e2mxR_zJinbnTZoPc6YJxzx2ougXEmxCtQJhuuWN0W9PML9DHOKZQ99hS0TKmmUJ-eqLkfceg2yY06bbvnaArADoBJMeeE9g_CoNvF3x3i70r83S7-budSvtAYN-nJxTAl7fx_lfygzGVKuYP0l-l_in4DCCnDVg |
CitedBy_id | crossref_primary_10_1016_j_jim_2020_112846 crossref_primary_10_1016_j_vaccine_2019_01_035 crossref_primary_10_1016_j_vaccine_2020_02_088 crossref_primary_10_1007_s15010_023_02054_3 crossref_primary_10_1542_peds_2014_3907 crossref_primary_10_1007_s00430_014_0346_1 crossref_primary_10_1093_ofid_ofad497 crossref_primary_10_3389_fimmu_2019_02496 crossref_primary_10_1016_j_clim_2020_108491 crossref_primary_10_1002_cam4_2253 crossref_primary_10_3389_fimmu_2017_01862 crossref_primary_10_1007_s00112_022_01432_9 crossref_primary_10_1007_s12016_021_08860_7 crossref_primary_10_3109_10408444_2015_1122573 crossref_primary_10_1080_15321819_2017_1340897 |
Cites_doi | 10.1016/j.vaccine.2007.01.119 10.1016/0022-1759(96)00033-6 10.1111/j.1365-2141.2009.07903.x 10.1097/01.inf.0000115737.35353.55 10.1097/01.mlg.0000171016.82850.41 10.1111/j.1365-2249.2006.03138.x 10.1016/S0264-410X(98)00475-7 10.1086/431679 10.1073/pnas.230417497 10.1086/513199 10.1086/422395 10.1086/422531 10.1038/sj.bmt.1701967 10.1111/j.1365-2249.2006.03242.x 10.1016/0091-6749(93)90303-W 10.1016/S0091-6749(96)80078-9 10.1046/j.1365-2249.2003.02232.x 10.1046/j.1440-1754.2001.00687.x 10.1016/S0091-6749(98)70089-2 10.1016/j.vaccine.2009.06.054 10.1128/CDLI.12.10.1216-1222.2005 10.1128/CDLI.6.3.446-446.1999 10.1128/CDLI.10.2.202-207.2003 10.1128/CDLI.8.2.266-272.2001 |
ContentType | Journal Article |
Copyright | Springer-Verlag Berlin Heidelberg 2013 |
Copyright_xml | – notice: Springer-Verlag Berlin Heidelberg 2013 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7U9 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7N M7P MBDVC P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U RC3 7X8 7QL C1K |
DOI | 10.1007/s00430-013-0292-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE - Academic MEDLINE Research Library Prep AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1432-1831 |
EndPage | 294 |
ExternalDocumentID | 3033678161 23529214 10_1007_s00430_013_0292_3 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3SX 3V. 4.4 406 408 409 40D 40E 53G 5QI 5VS 67N 67Z 6NX 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFFNX AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EDH EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GUQSH GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LK8 LLZTM M1P M2O M4Y M7P MA- MM. N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PF0 PQQKQ PROAC PSQYO PT4 PT5 PZZ Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 X7M YLTOR Z45 Z7U Z87 Z8O Z91 ZGI ZMTXR ZOVNA ZXP ~A9 ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7T5 7U9 7XB 8FD 8FK ABRTQ FR3 H94 K9. M7N MBDVC P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS PUEGO Q9U RC3 7X8 7QL C1K |
ID | FETCH-LOGICAL-c405t-3824081ef352acb9323f0c77f1cca575668c75a08bfa5cb6a84e9d3daeb77de3 |
IEDL.DBID | AGYKE |
ISSN | 0300-8584 1432-1831 |
IngestDate | Fri Sep 05 08:56:06 EDT 2025 Fri Sep 05 07:13:07 EDT 2025 Sat Aug 23 13:35:16 EDT 2025 Wed Feb 19 02:16:14 EST 2025 Thu Apr 24 22:58:02 EDT 2025 Tue Jul 01 00:53:47 EDT 2025 Fri Feb 21 02:35:43 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Screening Cutoff levels Pneumococcal antibodies Reference values Immunodeficiency |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c405t-3824081ef352acb9323f0c77f1cca575668c75a08bfa5cb6a84e9d3daeb77de3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 23529214 |
PQID | 1417061885 |
PQPubID | 47200 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1427012133 proquest_miscellaneous_1417528146 proquest_journals_1417061885 pubmed_primary_23529214 crossref_primary_10_1007_s00430_013_0292_3 crossref_citationtrail_10_1007_s00430_013_0292_3 springer_journals_10_1007_s00430_013_0292_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20130800 2013-8-00 2013-Aug 20130801 |
PublicationDateYYYYMMDD | 2013-08-01 |
PublicationDate_xml | – month: 8 year: 2013 text: 20130800 |
PublicationDecade | 2010 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Berlin |
PublicationTitle | Medical microbiology and immunology |
PublicationTitleAbbrev | Med Microbiol Immunol |
PublicationTitleAlternate | Med Microbiol Immunol |
PublicationYear | 2013 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | Madore, Quataert, Mariani, Berbers (CR6) 1999; 6 Ochsenbein, Pinschewer, Sierro, Horvath, Hengartner, Zinkernagel (CR11) 2000; 97 Lehrnbecher, Schubert, Behl, Koenig, Rose, Koehl (CR26) 2009; 147 Sanders, Rijkers, Kuis (CR8) 1993; 91 Rose, Schubert, Strnad, Zielen (CR25) 2005; 12 Hey, Rose, Kujumdshiev, Gstoettner, Schubert, Zielen (CR16) 2005; 115 Boyle, Le, Balloch, Tang (CR24) 2006; 146 Siber, Chang, Baker, Fernsten, O’Brien, Santosham, Klugman (CR7) 2007; 25 Soininen, Seppala, Nieminen, Eskola, Kayhty (CR23) 1999; 17 Zielen, Bröker, Strnad, Schwenen, Schön, Gottwald, Hofmann (CR3) 1996; 193 Schubert, Reichenbach, Rose, Zielen (CR9) 2004; 23 Millar, O’Brien, Bronsdon, Madore, Hackell, Reid, Santosham (CR21) 2007; 44 Balmer, North, Baxter, Stanford, Melegaro, Kaczmarski, Miller, Borrow (CR18) 2003; 133 de Vries (CR1) 2005; 145 Rose, Gruendler, Schubert, Kitz, Schulze, Rosewich, Zielen (CR27) 2009; 27 Lau, Bettelheim, Patel (CR15) 1988; 101 Rose, Hey, Kujumdshiew, Gall, Schubert, Zielen (CR17) 2004; 190 CR5 Dagan, Givon-Lavi, Fraser, Lipsitch, Siber, Kohberger (CR20) 2005; 192 Akikusa, Kemp (CR10) 2001; 37 Parkkali, Kayhty, Anttila, Ruutu, Wuorimaa, Soininen (CR22) 1999; 24 Sorensen, Leiva, Javier, Sacerdote, Bradford, Butler, Giangrosso, Moore (CR13) 1998; 102 Jokinen, Ahman, Kilpi, Makela, Kayhty (CR19) 2004; 190 Concepcion, Frasch (CR4) 2001; 8 Schauer, Stemberg, Rieger, Büttner, Borte, Schubert (CR2) 2003; 10 Peset Llopis, Harms, Hardonk, Timens (CR12) 1996; 97 Soininen, Karpala, Wahlman, Lehtonen, Kayhty (CR14) 2002; 9 EAM Sanders (292_CR8) 1993; 91 RJ Boyle (292_CR24) 2006; 146 MA Rose (292_CR27) 2009; 27 P Balmer (292_CR18) 2003; 133 JD Akikusa (292_CR10) 2001; 37 EV Millar (292_CR21) 2007; 44 MA Rose (292_CR17) 2004; 190 S Zielen (292_CR3) 1996; 193 R Schubert (292_CR9) 2004; 23 292_CR5 RC Lau (292_CR15) 1988; 101 T Parkkali (292_CR22) 1999; 24 T Lehrnbecher (292_CR26) 2009; 147 JT Jokinen (292_CR19) 2004; 190 E Vries de (292_CR1) 2005; 145 AF Ochsenbein (292_CR11) 2000; 97 U Schauer (292_CR2) 2003; 10 MA Rose (292_CR25) 2005; 12 C Hey (292_CR16) 2005; 115 DV Madore (292_CR6) 1999; 6 NF Concepcion (292_CR4) 2001; 8 RU Sorensen (292_CR13) 1998; 102 GR Siber (292_CR7) 2007; 25 A Soininen (292_CR14) 2002; 9 A Soininen (292_CR23) 1999; 17 R Dagan (292_CR20) 2005; 192 MJ Peset Llopis (292_CR12) 1996; 97 15243931 - J Infect Dis. 2004 Aug 1;190(3):551-7 11532059 - J Paediatr Child Health. 2001 Aug;37(4):382-7 16879238 - Clin Exp Immunol. 2006 Aug;145(2):204-14 17368878 - Vaccine. 2007 May 10;25(19):3816-26 8655878 - J Allergy Clin Immunol. 1996 Apr;97(4):1015-24 10217586 - Vaccine. 1999 Apr 9;17(15-16):1889-97 19764991 - Br J Haematol. 2009 Dec;147(5):700-5 8423268 - J Allergy Clin Immunol. 1993 Jan;91(1 Pt 1):110-9 17100769 - Clin Exp Immunol. 2006 Dec;146(3):486-92 15995949 - J Infect Dis. 2005 Aug 1;192(3):367-76 12626443 - Clin Diagn Lab Immunol. 2003 Mar;10(2):202-7 10490735 - Bone Marrow Transplant. 1999 Sep;24(6):671-8 11069289 - Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13263-8 17407035 - Clin Infect Dis. 2007 May 1;44(9):1173-9 15014308 - Pediatr Infect Dis J. 2004 Mar;23(3):269-70 10490332 - Clin Diagn Lab Immunol. 1999 May;6(3):446 8690926 - J Immunol Methods. 1996 Jun 14;193(1):1-7 15243930 - J Infect Dis. 2004 Aug 1;190(3):545-50 3194078 - N Z Med J. 1988 Nov 23;101(858):797-800 12204955 - Clin Diagn Lab Immunol. 2002 Sep;9(5):1032-8 12930362 - Clin Exp Immunol. 2003 Sep;133(3):364-9 19576944 - Vaccine. 2009 Aug 20;27(38):5259-64 9723664 - J Allergy Clin Immunol. 1998 Aug;102(2):215-21 16210486 - Clin Diagn Lab Immunol. 2005 Oct;12(10):1216-22 16148699 - Laryngoscope. 2005 Sep;115(9):1586-90 11238206 - Clin Diagn Lab Immunol. 2001 Mar;8(2):266-72 |
References_xml | – volume: 25 start-page: 3816 issue: 19 year: 2007 end-page: 3826 ident: CR7 article-title: Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies publication-title: Vaccine doi: 10.1016/j.vaccine.2007.01.119 – volume: 193 start-page: 1 issue: 1 year: 1996 end-page: 7 ident: CR3 article-title: Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA-Plates publication-title: J Immunol Methods doi: 10.1016/0022-1759(96)00033-6 – volume: 12 start-page: 1216 issue: 10 year: 2005 end-page: 1222 ident: CR25 article-title: Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine publication-title: Clin Diagn Lab Immunol – volume: 147 start-page: 700 issue: 5 year: 2009 end-page: 705 ident: CR26 article-title: Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2009.07903.x – volume: 23 start-page: 269 issue: 3 year: 2004 end-page: 270 ident: CR9 article-title: Immunogenicity of the 7-valent pneumococcal conjugate vaccine in patients with ataxia telangiectasia publication-title: Pediatr Infect Dis J doi: 10.1097/01.inf.0000115737.35353.55 – volume: 115 start-page: 1586 issue: 9 year: 2005 end-page: 1590 ident: CR16 article-title: Does the 23-valent pneumococcal vaccine protect cochlear implant recipients? publication-title: Laryngoscope doi: 10.1097/01.mlg.0000171016.82850.41 – volume: 145 start-page: 204 year: 2005 end-page: 214 ident: CR1 article-title: Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2006.03138.x – volume: 8 start-page: 266 year: 2001 end-page: 272 ident: CR4 article-title: Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay publication-title: Clin Diagn Lab Immunol – volume: 10 start-page: 202 issue: 2 year: 2003 end-page: 207 ident: CR2 article-title: Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type B, and pneumococcal capsular polysaccharide in healthy children and adults publication-title: Clin Diagn Lab Immunol – volume: 17 start-page: 1889 year: 1999 end-page: 1897 ident: CR23 article-title: IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines publication-title: Vaccine doi: 10.1016/S0264-410X(98)00475-7 – volume: 192 start-page: 367 issue: 3 year: 2005 end-page: 376 ident: CR20 article-title: Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus publication-title: J Infect Dis doi: 10.1086/431679 – volume: 97 start-page: 13263 year: 2000 end-page: 13268 ident: CR11 article-title: Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.230417497 – volume: 9 start-page: 1032 year: 2002 end-page: 1038 ident: CR14 article-title: Specificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children publication-title: Clin Diagn Lab Immunol – volume: 44 start-page: 1173 issue: 9 year: 2007 end-page: 1179 ident: CR21 article-title: Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine publication-title: Clin Infect Dis doi: 10.1086/513199 – volume: 190 start-page: 551 year: 2004 end-page: 557 ident: CR17 article-title: Immunogenicity of pneumococcal vaccination in patients with cochlear implants publication-title: J Infect Dis doi: 10.1086/422395 – volume: 190 start-page: 545 year: 2004 end-page: 550 ident: CR19 article-title: Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media publication-title: J Infect Dis doi: 10.1086/422531 – volume: 24 start-page: 671 year: 1999 end-page: 678 ident: CR22 article-title: IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines publication-title: Bone Marrow Transplant doi: 10.1038/sj.bmt.1701967 – volume: 146 start-page: 486 year: 2006 end-page: 492 ident: CR24 article-title: The clinical syndrome of specific antibody deficiency in children publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2006.03242.x – volume: 91 start-page: 110 year: 1993 end-page: 119 ident: CR8 article-title: Defective anti-pneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections publication-title: J Allergy Clin Immunol doi: 10.1016/0091-6749(93)90303-W – volume: 97 start-page: 1015 year: 1996 end-page: 1024 ident: CR12 article-title: Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(96)80078-9 – volume: 101 start-page: 797 year: 1988 end-page: 800 ident: CR15 article-title: The 1985 national immunization survey: diphtheria, tetanus, and pertussis publication-title: NZ Med J – volume: 6 start-page: 446 year: 1999 ident: CR6 article-title: Interlaboratory reproducibility of an enzyme-linked immunosorbent assay for quantitation of antibodies for Haemophilus influenzae type b polysaccharide publication-title: Clin Diagn Lab Immunol – volume: 133 start-page: 364 issue: 3 year: 2003 end-page: 369 ident: CR18 article-title: Measurement and interpretation of pneumococcal IgG levels for clinical management publication-title: Clin Exp Immunol doi: 10.1046/j.1365-2249.2003.02232.x – ident: CR5 – volume: 37 start-page: 382 year: 2001 end-page: 387 ident: CR10 article-title: Clinical correlates of response to pneumococcal immunization publication-title: J Paediatr Child Health doi: 10.1046/j.1440-1754.2001.00687.x – volume: 102 start-page: 215 year: 1998 end-page: 221 ident: CR13 article-title: Influence of age on the response to vaccine in patients with recurrent infections and normal immunoglobulin concentrations publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(98)70089-2 – volume: 27 start-page: 5259 issue: 38 year: 2009 end-page: 5264 ident: CR27 article-title: Safety and immunogenicity of sequential pneumococcal immunization in preschool asthmatics publication-title: Vaccine doi: 10.1016/j.vaccine.2009.06.054 – volume: 24 start-page: 671 year: 1999 ident: 292_CR22 publication-title: Bone Marrow Transplant doi: 10.1038/sj.bmt.1701967 – volume: 37 start-page: 382 year: 2001 ident: 292_CR10 publication-title: J Paediatr Child Health doi: 10.1046/j.1440-1754.2001.00687.x – volume: 12 start-page: 1216 issue: 10 year: 2005 ident: 292_CR25 publication-title: Clin Diagn Lab Immunol doi: 10.1128/CDLI.12.10.1216-1222.2005 – volume: 6 start-page: 446 year: 1999 ident: 292_CR6 publication-title: Clin Diagn Lab Immunol doi: 10.1128/CDLI.6.3.446-446.1999 – volume: 190 start-page: 551 year: 2004 ident: 292_CR17 publication-title: J Infect Dis doi: 10.1086/422395 – volume: 23 start-page: 269 issue: 3 year: 2004 ident: 292_CR9 publication-title: Pediatr Infect Dis J doi: 10.1097/01.inf.0000115737.35353.55 – volume: 133 start-page: 364 issue: 3 year: 2003 ident: 292_CR18 publication-title: Clin Exp Immunol doi: 10.1046/j.1365-2249.2003.02232.x – volume: 97 start-page: 13263 year: 2000 ident: 292_CR11 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.230417497 – volume: 10 start-page: 202 issue: 2 year: 2003 ident: 292_CR2 publication-title: Clin Diagn Lab Immunol doi: 10.1128/CDLI.10.2.202-207.2003 – volume: 145 start-page: 204 year: 2005 ident: 292_CR1 publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2006.03138.x – volume: 190 start-page: 545 year: 2004 ident: 292_CR19 publication-title: J Infect Dis doi: 10.1086/422531 – volume: 102 start-page: 215 year: 1998 ident: 292_CR13 publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(98)70089-2 – volume: 193 start-page: 1 issue: 1 year: 1996 ident: 292_CR3 publication-title: J Immunol Methods doi: 10.1016/0022-1759(96)00033-6 – volume: 8 start-page: 266 year: 2001 ident: 292_CR4 publication-title: Clin Diagn Lab Immunol doi: 10.1128/CDLI.8.2.266-272.2001 – ident: 292_CR5 – volume: 101 start-page: 797 year: 1988 ident: 292_CR15 publication-title: NZ Med J – volume: 97 start-page: 1015 year: 1996 ident: 292_CR12 publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(96)80078-9 – volume: 192 start-page: 367 issue: 3 year: 2005 ident: 292_CR20 publication-title: J Infect Dis doi: 10.1086/431679 – volume: 17 start-page: 1889 year: 1999 ident: 292_CR23 publication-title: Vaccine doi: 10.1016/S0264-410X(98)00475-7 – volume: 91 start-page: 110 year: 1993 ident: 292_CR8 publication-title: J Allergy Clin Immunol doi: 10.1016/0091-6749(93)90303-W – volume: 25 start-page: 3816 issue: 19 year: 2007 ident: 292_CR7 publication-title: Vaccine doi: 10.1016/j.vaccine.2007.01.119 – volume: 44 start-page: 1173 issue: 9 year: 2007 ident: 292_CR21 publication-title: Clin Infect Dis doi: 10.1086/513199 – volume: 147 start-page: 700 issue: 5 year: 2009 ident: 292_CR26 publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2009.07903.x – volume: 9 start-page: 1032 year: 2002 ident: 292_CR14 publication-title: Clin Diagn Lab Immunol – volume: 115 start-page: 1586 issue: 9 year: 2005 ident: 292_CR16 publication-title: Laryngoscope doi: 10.1097/01.mlg.0000171016.82850.41 – volume: 146 start-page: 486 year: 2006 ident: 292_CR24 publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2006.03242.x – volume: 27 start-page: 5259 issue: 38 year: 2009 ident: 292_CR27 publication-title: Vaccine doi: 10.1016/j.vaccine.2009.06.054 – reference: 15243930 - J Infect Dis. 2004 Aug 1;190(3):545-50 – reference: 10217586 - Vaccine. 1999 Apr 9;17(15-16):1889-97 – reference: 16879238 - Clin Exp Immunol. 2006 Aug;145(2):204-14 – reference: 16210486 - Clin Diagn Lab Immunol. 2005 Oct;12(10):1216-22 – reference: 10490332 - Clin Diagn Lab Immunol. 1999 May;6(3):446 – reference: 11532059 - J Paediatr Child Health. 2001 Aug;37(4):382-7 – reference: 15243931 - J Infect Dis. 2004 Aug 1;190(3):551-7 – reference: 17100769 - Clin Exp Immunol. 2006 Dec;146(3):486-92 – reference: 8690926 - J Immunol Methods. 1996 Jun 14;193(1):1-7 – reference: 8655878 - J Allergy Clin Immunol. 1996 Apr;97(4):1015-24 – reference: 10490735 - Bone Marrow Transplant. 1999 Sep;24(6):671-8 – reference: 12204955 - Clin Diagn Lab Immunol. 2002 Sep;9(5):1032-8 – reference: 17368878 - Vaccine. 2007 May 10;25(19):3816-26 – reference: 15995949 - J Infect Dis. 2005 Aug 1;192(3):367-76 – reference: 3194078 - N Z Med J. 1988 Nov 23;101(858):797-800 – reference: 19576944 - Vaccine. 2009 Aug 20;27(38):5259-64 – reference: 9723664 - J Allergy Clin Immunol. 1998 Aug;102(2):215-21 – reference: 19764991 - Br J Haematol. 2009 Dec;147(5):700-5 – reference: 8423268 - J Allergy Clin Immunol. 1993 Jan;91(1 Pt 1):110-9 – reference: 11238206 - Clin Diagn Lab Immunol. 2001 Mar;8(2):266-72 – reference: 15014308 - Pediatr Infect Dis J. 2004 Mar;23(3):269-70 – reference: 11069289 - Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13263-8 – reference: 12930362 - Clin Exp Immunol. 2003 Sep;133(3):364-9 – reference: 16148699 - Laryngoscope. 2005 Sep;115(9):1586-90 – reference: 17407035 - Clin Infect Dis. 2007 May 1;44(9):1173-9 – reference: 12626443 - Clin Diagn Lab Immunol. 2003 Mar;10(2):202-7 |
SSID | ssj0017620 |
Score | 2.0649796 |
Snippet | Pneumococcal antibodies represent the acquisition of natural immunity. Determination of pneumococcal antibodies is an important screening tool for... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 285 |
SubjectTerms | Adolescent Adult Adults Age Factors Antibodies, Bacterial - blood Biomedical and Life Sciences Biomedicine Child Child, Preschool Children & youth Enzyme-Linked Immunosorbent Assay Female Health Healthy Volunteers Humans Immunoglobulin G - blood Immunology Infant Male Medical Microbiology Middle Aged Monoclonal antibodies Original Investigation Reference Values Sensitivity and Specificity Serum - immunology Streptococcus pneumoniae Streptococcus pneumoniae - immunology Virology Young Adult |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9UwDI9gXJAQ4psHAwWJAx-KSJO0TU4IIcZAgtOQ3mlVmibTpK19rO3h_S37Z2cnbQFNvFNV1W2t2Ens2P6ZkNe8gCmmdGCm4Zop2JCZsZjskNfCCOeUj10UfvwsDn-p7-t8PR249VNa5bwmxoW66RyekX_IFAK9ZFrnHze_GXaNwujq1ELjJrkVoctAn8v14nBlMNF5iiJwpmGnnaOaPIGISkzJwiimEUz-uy9dMzavBUrj_nNwj9ydDEf6KUn6Prnh2wfkTjp1o6mY6CG5XHBj6QVWDfTUtg1149CFQM8wP6inXaCb1o_nHSyFICCgGE7rrtnShA1CQSfHcwo2td329M23k6_xG3A97seaiuO38R4rNDHLaH4dHG562tJUVrmlc414pI0YH_0jcnTw5ejzIZvaLzAHVtzApEb4s8wHsNGsq8HQk4G7sgwZcAdWXlFoV-aW6zrY3NWF1cqbRjbW12XZePmY7LVd658SqhplgiwldmEHD8sar5wLBUffjwdtVoTPY1-5CZocO2ScVQuochRXBeKqUFyVXJF3yyubhMuxi3h_Fmg1TdG--qNQK_JqeQyTCyMmtvXdmGhygaeku2hEGYHx4DdPkrIsHAkYOiMytSLvZ-35i4H_sftsN7vPyW0R9RazEPfJ3nAx-hdgGQ31y6j-V2zzB8A priority: 102 providerName: ProQuest |
Title | Reference ranges and cutoff levels of pneumococcal antibody global serum assays (IgG and IgG2) and specific antibodies in healthy children and adults |
URI | https://link.springer.com/article/10.1007/s00430-013-0292-3 https://www.ncbi.nlm.nih.gov/pubmed/23529214 https://www.proquest.com/docview/1417061885 https://www.proquest.com/docview/1417528146 https://www.proquest.com/docview/1427012133 |
Volume | 202 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7R7QUJQXmVhbIyEgceSpWHEzvH3Wq3BcQKoa20nCLHsauqbVI1yWH5H_xfxnYSFQqVeokjZeJM7Jl4nJn5BuCtn6CKUa69tPC5R3FB9lJhgh3iPExDKamyVRS-LpOjY_p5Ha-7PO66j3bvXZL2Sz0ku1l4Ks9WI8BuvGgLtuOAp3wE29PDH1_mg_MA9dt3zgPf47jA9s7Mf3Xy53J0w8a84R-1y87iEax6hl20ydl-2-T78udfWI53fKMdeNiZoWTq5OYx3FPlE3jg_uERl5r0FH4NKLTkyuQg1ESUBZFtU2lNzk20UU0qTS5L1V5U-GHF6UaK5jSvig1xSCMEJby9IGihi01N3n06ObR9YBu-t2cm09NEK_U34sadnJbEpWduSJ9rbmktVkj9DFaL-ergyOvKOHgSrcHGi7iBUQuURltPyBwNxkj7kjEdIF9oLSYJlywWPs-1iGWeCE5VWkSFUDljhYqew6isSvUCCC1oqiMWmWruuFMTqaJS6sQ3e0hf83QMfj-Zmewgzk2ljfNsAGe2Q57hkGdmyLNoDB-GWy4dvsdtxHu9hGSdqte4dzIIRAHn8RjeDJdRSY3nRZSqah1NHJq_rbfRhMwC7OFjdp30DRyFOHRpGNAxfOwl6RoD_2P35Z2oX8H90IqiCW7cg1Fz1arXaHA1-QS22JrhkR8EE1S2xWy2nHRKh-1svvz2Ha8eh9Pf7BskcA |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbK9gASQrxZKGAkkHgownGcxDkgxKNll7YrhLZST40cx0aV2mRpEqH9LfwG_iMz9iaAKvbWUxRlkjiZh8eemW8IecoSUDEhbZCVTAYCJuQgU5jsEBc841oL47oo7M-SyYH4fBgfbpBffS0MplX2NtEZ6rLWuEf-OhQI9BJKGb9dfA-waxRGV_sWGl4sds3yByzZmjfTj8DfZ5zvbM8_TIJVV4FAg3PSBpFEVK_QWHA9lC7Af4ks02lqQ_gYcF6SROo0VkwWVsW6SJQUJiujUpkiTUsTwWMvkU2BBa0jsvl-e_bl6xC2AMvCfNiCBRKm9j6MyjxqaYQ5YBg2zXgQ_TsRnvNuz0Vm3YS3c51cW3mq9J0XrRtkw1Q3yVW_zUd99dIt8nMAqqVnWKbQUFWVVHdtbS09wYSkhtaWLirTndZge0EigKI9LupyST0YCQUl6E4pOPFq2dDn02-f3DPgeNR0BeVHL9w5loRiWlN_O6zw6XFFfR3nkvZF6Y7WgYo0t8n8Ijhzh4yqujL3CBWlyGyURtj2HZZ0KjNCa5swXGwyK7MxYf2_z_UKCx1bcpzkA4qzY1cO7MqRXXk0Ji-HWxYeCGQd8VbP0HxlE5r8jwSPyZPhMmgzhmhUZerO08Qct2XX0fDUIfHBa-56YRlGxOHXZTwUY_Kql56_BvC_4d5fP9zH5PJkvr-X701nuw_IFe5kGFMgt8ioPevMQ3DL2uLRShkoyS9Y_X4DF3VGjw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fa9RAEF9qBRFE_O9p1RUU1BK62d0kmwcRsZ49q8WHCvfUsNnsSqFNziZB7rP4Sfx2zuxeolK8tz4dx01ym8yfndmZ-Q0hz1gKKiaVi_KKqUjChhzlGosdkpLn3Bhp_RSFzwfp3lf5cZ7MN8ivoRcGyyoHm-gNddUYPCPfiSUCvcRKJTtuVRbxZXf6ZvE9wglSmGkdxmkEEdm3yx8QvrWvZ7vA6-ecT98fvtuLVhMGIgOOShcJhQhfsXXghmhTgi8jHDNZ5mJ4MHBk0lSZLNFMlU4npky1kjavRKVtmWWVFXDbS-RyJsCpAlXK5mOsF4ONYSGBwSIFm_yQUGUBv1RgNRgmUHMeiX-3xHN-7rkcrd_6pjfI9ZXPSt8GIbtJNmx9i1wLB3409DHdJj9HyFp6hg0LLdV1RU3fNc7REyxNamnj6KK2_WkDVhhkAyi647KpljTAklBQh_6Ugjuvly19Mfv2wd8DPo_avqT86KX_js2hWOA0XA6xPj2uaejoXNKhPd3TeniR9g45vAi-3CWbdVPb-4TKSuZOZAIHwENwp3MrjXEpw7CTOZVPCBvefWFWqOg4nOOkGPGcPbsKYFeB7CrEhLwaL1kESJB1xFsDQ4uVdWiLP7I8IU_Hn0GvMVmja9v0gSbheEC7joZnHpMP_uZeEJZxRRxeXc5jOSHbg_T8tYD_LffB-uU-IVdA6YpPs4P9h-Qq9yKMtZBbZLM76-0j8M-68rHXBEqKC9a836_hSVY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reference+ranges+and+cutoff+levels+of+pneumococcal+antibody+global+serum+assays+%28IgG+and+IgG2%29+and+specific+antibodies+in+healthy+children+and+adults&rft.jtitle=Medical+microbiology+and+immunology&rft.au=Rose%2C+M+A&rft.au=Buess%2C+J&rft.au=Ventur%2C+Y&rft.au=Zielen%2C+S&rft.date=2013-08-01&rft.issn=1432-1831&rft.eissn=1432-1831&rft.volume=202&rft.issue=4&rft.spage=285&rft_id=info:doi/10.1007%2Fs00430-013-0292-3&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-8584&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-8584&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-8584&client=summon |